Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis

Gregory G. Burrows, Wouter Van't Hof, Laura Newell, Ashok Reddy, Phillip Wilmarth, Larry David, Amy Raber, Annelies Bogaerts, Jef Pinxteren, Robert J. Deans, Richard Maziarz

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Multipotent adult progenitor cells (MAPCs) are adult adherent stromal stem cells currently being assessed in acute graft versus host disease clinical trials with demonstrated immunomodulatory capabilities and the potential to ameliorate detrimental autoimmune and inflammation-related processes. Our previous studies documented that MAPCs secrete factors that play a role in regulating T-cell activity. Here we expand our studies using a proteomics approach to characterize and quantify MAPC secretome components secreted over 72 hours in vitro under steady-state conditions and in the presence of the inflammatory triggers interferon-γ and lipopolysaccharide, or a tolerogenic CD74 ligand, RTL1000. MAPCs differentially responded to each of the tested stimuli, secreting molecules that regulate the biological activity of the extracellular matrix (ECM), including proteins that make up the ECM itself, proteins that regulate its construction/deconstruction, and proteins that serve to attach and detach growth factors from ECM components for redistribution upon appropriate stimulation. MAPCs secreted a wide array of proteases, some detectable in their zymogen forms. MAPCs also secreted protease inhibitors that would regulate protease activity. MAPCs secreted chemokines and cytokines that could provide molecular guidance cues to various cell types, including neutrophils, macrophages, and T cells. In addition, MAPCs secreted factors involved in maintenance of a homeostatic environment, regulating such diverse programs as innate immunity, angiogenesis/angiostasis, targeted delivery of growth factors, and the matrix-metalloprotease cascade.

Original languageEnglish (US)
Pages (from-to)745-757
Number of pages13
JournalStem cells translational medicine
Volume2
Issue number10
DOIs
StatePublished - Oct 2013

Fingerprint

Proteomics
Dissection
Stem Cells
Extracellular Matrix Proteins
Intercellular Signaling Peptides and Proteins
Peptide Hydrolases
T-Lymphocytes
Enzyme Precursors
Metalloproteases
Graft vs Host Disease
Cellular Structures
Stromal Cells
Protease Inhibitors
Chemokines
Innate Immunity
Interferons
Cues
Extracellular Matrix
Lipopolysaccharides
Neutrophils

Keywords

  • Adult hematopoietic stem cells
  • Graft versus host disease
  • Immunotherapy
  • Mesenchymal stem cells
  • Proteomics
  • RTL1000
  • Tolerance

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. / Burrows, Gregory G.; Van't Hof, Wouter; Newell, Laura; Reddy, Ashok; Wilmarth, Phillip; David, Larry; Raber, Amy; Bogaerts, Annelies; Pinxteren, Jef; Deans, Robert J.; Maziarz, Richard.

In: Stem cells translational medicine, Vol. 2, No. 10, 10.2013, p. 745-757.

Research output: Contribution to journalArticle

Burrows, Gregory G. ; Van't Hof, Wouter ; Newell, Laura ; Reddy, Ashok ; Wilmarth, Phillip ; David, Larry ; Raber, Amy ; Bogaerts, Annelies ; Pinxteren, Jef ; Deans, Robert J. ; Maziarz, Richard. / Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. In: Stem cells translational medicine. 2013 ; Vol. 2, No. 10. pp. 745-757.
@article{ebae7d8decf346ba829f6c023f6cd518,
title = "Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis",
abstract = "Multipotent adult progenitor cells (MAPCs) are adult adherent stromal stem cells currently being assessed in acute graft versus host disease clinical trials with demonstrated immunomodulatory capabilities and the potential to ameliorate detrimental autoimmune and inflammation-related processes. Our previous studies documented that MAPCs secrete factors that play a role in regulating T-cell activity. Here we expand our studies using a proteomics approach to characterize and quantify MAPC secretome components secreted over 72 hours in vitro under steady-state conditions and in the presence of the inflammatory triggers interferon-γ and lipopolysaccharide, or a tolerogenic CD74 ligand, RTL1000. MAPCs differentially responded to each of the tested stimuli, secreting molecules that regulate the biological activity of the extracellular matrix (ECM), including proteins that make up the ECM itself, proteins that regulate its construction/deconstruction, and proteins that serve to attach and detach growth factors from ECM components for redistribution upon appropriate stimulation. MAPCs secreted a wide array of proteases, some detectable in their zymogen forms. MAPCs also secreted protease inhibitors that would regulate protease activity. MAPCs secreted chemokines and cytokines that could provide molecular guidance cues to various cell types, including neutrophils, macrophages, and T cells. In addition, MAPCs secreted factors involved in maintenance of a homeostatic environment, regulating such diverse programs as innate immunity, angiogenesis/angiostasis, targeted delivery of growth factors, and the matrix-metalloprotease cascade.",
keywords = "Adult hematopoietic stem cells, Graft versus host disease, Immunotherapy, Mesenchymal stem cells, Proteomics, RTL1000, Tolerance",
author = "Burrows, {Gregory G.} and {Van't Hof}, Wouter and Laura Newell and Ashok Reddy and Phillip Wilmarth and Larry David and Amy Raber and Annelies Bogaerts and Jef Pinxteren and Deans, {Robert J.} and Richard Maziarz",
year = "2013",
month = "10",
doi = "10.5966/sctm.2013-0031",
language = "English (US)",
volume = "2",
pages = "745--757",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "10",

}

TY - JOUR

T1 - Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis

AU - Burrows, Gregory G.

AU - Van't Hof, Wouter

AU - Newell, Laura

AU - Reddy, Ashok

AU - Wilmarth, Phillip

AU - David, Larry

AU - Raber, Amy

AU - Bogaerts, Annelies

AU - Pinxteren, Jef

AU - Deans, Robert J.

AU - Maziarz, Richard

PY - 2013/10

Y1 - 2013/10

N2 - Multipotent adult progenitor cells (MAPCs) are adult adherent stromal stem cells currently being assessed in acute graft versus host disease clinical trials with demonstrated immunomodulatory capabilities and the potential to ameliorate detrimental autoimmune and inflammation-related processes. Our previous studies documented that MAPCs secrete factors that play a role in regulating T-cell activity. Here we expand our studies using a proteomics approach to characterize and quantify MAPC secretome components secreted over 72 hours in vitro under steady-state conditions and in the presence of the inflammatory triggers interferon-γ and lipopolysaccharide, or a tolerogenic CD74 ligand, RTL1000. MAPCs differentially responded to each of the tested stimuli, secreting molecules that regulate the biological activity of the extracellular matrix (ECM), including proteins that make up the ECM itself, proteins that regulate its construction/deconstruction, and proteins that serve to attach and detach growth factors from ECM components for redistribution upon appropriate stimulation. MAPCs secreted a wide array of proteases, some detectable in their zymogen forms. MAPCs also secreted protease inhibitors that would regulate protease activity. MAPCs secreted chemokines and cytokines that could provide molecular guidance cues to various cell types, including neutrophils, macrophages, and T cells. In addition, MAPCs secreted factors involved in maintenance of a homeostatic environment, regulating such diverse programs as innate immunity, angiogenesis/angiostasis, targeted delivery of growth factors, and the matrix-metalloprotease cascade.

AB - Multipotent adult progenitor cells (MAPCs) are adult adherent stromal stem cells currently being assessed in acute graft versus host disease clinical trials with demonstrated immunomodulatory capabilities and the potential to ameliorate detrimental autoimmune and inflammation-related processes. Our previous studies documented that MAPCs secrete factors that play a role in regulating T-cell activity. Here we expand our studies using a proteomics approach to characterize and quantify MAPC secretome components secreted over 72 hours in vitro under steady-state conditions and in the presence of the inflammatory triggers interferon-γ and lipopolysaccharide, or a tolerogenic CD74 ligand, RTL1000. MAPCs differentially responded to each of the tested stimuli, secreting molecules that regulate the biological activity of the extracellular matrix (ECM), including proteins that make up the ECM itself, proteins that regulate its construction/deconstruction, and proteins that serve to attach and detach growth factors from ECM components for redistribution upon appropriate stimulation. MAPCs secreted a wide array of proteases, some detectable in their zymogen forms. MAPCs also secreted protease inhibitors that would regulate protease activity. MAPCs secreted chemokines and cytokines that could provide molecular guidance cues to various cell types, including neutrophils, macrophages, and T cells. In addition, MAPCs secreted factors involved in maintenance of a homeostatic environment, regulating such diverse programs as innate immunity, angiogenesis/angiostasis, targeted delivery of growth factors, and the matrix-metalloprotease cascade.

KW - Adult hematopoietic stem cells

KW - Graft versus host disease

KW - Immunotherapy

KW - Mesenchymal stem cells

KW - Proteomics

KW - RTL1000

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=84884755521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884755521&partnerID=8YFLogxK

U2 - 10.5966/sctm.2013-0031

DO - 10.5966/sctm.2013-0031

M3 - Article

VL - 2

SP - 745

EP - 757

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 10

ER -